| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11010-012-1332-9 |
| P698 | PubMed publication ID | 22584587 |
| P2093 | author name string | Yan Liu | |
| Bin Zheng | |||
| Jin-kun Wen | |||
| Hui-jing Shi | |||
| Sui-bing Miao | |||
| P2860 | cites work | Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification | Q39908760 |
| hhLIM is a novel F-actin binding protein involved in actin cytoskeleton remodeling | Q40004030 | ||
| Human heart LIM protein activates atrial-natriuretic-factor gene expression by interacting with the cardiac-restricted transcription factor Nkx2.5. | Q40069876 | ||
| hhLIM is involved in cardiomyogenesis of embryonic stem cells | Q40314871 | ||
| Kruppel-like factor 5 shows proliferation-specific roles in vascular remodeling, direct stimulation of cell growth, and inhibition of apoptosis | Q43148405 | ||
| Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta | Q45042440 | ||
| PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells. | Q46491327 | ||
| Drosophila double-parked is sufficient to induce re-replication during development and is regulated by cyclin E/CDK2. | Q52087804 | ||
| Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1/2 and NF-kappaB. | Q53324906 | ||
| Mammalian Krüppel-Like Factors in Health and Diseases | Q24612560 | ||
| Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain | Q24648562 | ||
| MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation | Q24650539 | ||
| Krüppel-like factor 4 inhibits proliferation by platelet-derived growth factor receptor beta-mediated, not by retinoic acid receptor alpha-mediated, phosphatidylinositol 3-kinase and ERK signaling in vascular smooth muscle cells | Q28566073 | ||
| ATRA activates and PDGF-BB represses the SM22α promoter through KLF4 binding to, or dissociating from, its cis-DNA elements | Q28571337 | ||
| Synthetic retinoid Am80 inhibits interaction of KLF5 with RAR alpha through inducing KLF5 dephosphorylation mediated by the PI3K/Akt signaling in vascular smooth muscle cells | Q28574855 | ||
| Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells | Q30441514 | ||
| Vascular smooth muscle growth: autocrine growth mechanisms | Q34294052 | ||
| Resveratrol inhibits TNF-alpha-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells | Q34562979 | ||
| Transforming growth factor beta up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2 | Q36678525 | ||
| Acetylation of KLF5 alters the assembly of p15 transcription factors in transforming growth factor-beta-mediated induction in epithelial cells | Q37258607 | ||
| TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation | Q37298372 | ||
| Vascularizing the heart | Q37833832 | ||
| Roscovitine inhibits ERK1/2 activation induced by angiotensin II in vascular smooth muscle cells | Q38295283 | ||
| A novel roscovitine derivative potently induces G1-phase arrest in platelet-derived growth factor-BB-activated vascular smooth muscle cells | Q39776539 | ||
| Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells | Q39821441 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 185-194 | |
| P577 | publication date | 2012-05-15 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | KLF5 and hhLIM cooperatively promote proliferation of vascular smooth muscle cells | |
| P478 | volume | 367 |
| Q43159975 | Angiotensin II Downregulates MicroRNA-145 to Regulate Kruppel-like Factor 4 and Myocardin Expression in Human Coronary Arterial Smooth Muscle Cells under High Glucose Conditions |
| Q47676828 | Krüppel-like factors and vascular wall homeostasis. |
| Q36447499 | ML264, A Novel Small-Molecule Compound That Potently Inhibits Growth of Colorectal Cancer |
| Q45731738 | Methylation and expression of RECK, P53 and RUNX genes in patients with esophageal cancer |
| Q91911696 | Pioglitazone protects blood vessels through inhibition of the apelin signaling pathway by promoting KLF4 expression in rat models of T2DM |
| Q42489975 | SUMOylation of KLF4 acts as a switch in transcriptional programs that control VSMC proliferation |
| Q33826984 | Single-cell profiling reveals heterogeneity and functional patterning of GPCR expression in the vascular system |
| Q41098266 | Spatiotemporally Controlled Ablation of Klf5 Results in Dysregulated Epithelial Homeostasis in Adult Mouse Corneas |
| Q27022848 | The double life of KLF5: Opposing roles in regulation of gene-expression, cellular function, and transformation |
Search more.